This compound is an active pharmaceutical ingredient and a metabolite of ticagrelor, a platelet aggregation inhibitor that acts by antagonizing the P2Y12 receptor.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing AR-C124910XX?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Ticagrelor
pharmaceutical raw material
Deshydroxyethoxy-2,3-O-(dimethylmethylene) Ticagrelor
pharmaceutical intermediate
2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
pharmaceutical raw material
(1R,2S)-2-(3,4-Difluorophenyl)cyclopropanamine (2R,3R)-2,3-dihydroxybutanedioate
pharmaceutical raw material
Orobanchol
pharmaceutical raw material
Tigecycline
pharmaceutical raw material
Oteracil potassium
pharmaceutical raw material
Ticagrelor Sulfone
pharmaceutical raw material
(1S,2R,3S,4R)-4-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]cyclopentane-1,2,3-triol
XYLIQTKEYHWYGG-XUNGLMTJSA-N
CCCSC1=NC(=C2C(=N1)N(N=N2)[C@@H]3C[C@@H]([C@H]([C@H]3O)O)O)N[C@@H]4C[C@H]4C5=CC(=C(C=C5)F)F
Sourcing AR-C124910XX?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.